Gerhard Müller, PhD

Gerhard has a striking track record both in drug discovery and entrepreneurship. Throughout his career, Gerhard has worked on a wide range of different target classes in numerous disease areas. Gerhard’s expert knowledge in medicinal chemistry allowed him to establish novel design paradigms, proven by over 75 peer-reviewed publications and involvement of projects that translated into DC. He recently co-founded Anavo Therapeutics and prior to that he co-founded Gotham Therapeutics. Besides that, Gerhard has hold key positions at Mercachem, GPC Biotech, Axxima Pharmaceuticals, Glaxo, Bayer, and Organon.
Gerhard received his PhD in organic chemistry from the Technical University of Munich, where he worked with Prof. Dr. Horst Kessler on anti-adhesive integrin antagonists.